Apple is reportedly developing its smartwatch technologies through new partnerships

By Catherine Sturman
Share
Apple is continually developing its smartwatch capabilities, understanding that its innovations within healthcare will open the door to further market o...

Apple is continually developing its smartwatch capabilities, understanding that its innovations within healthcare will open the door to further market opportunities.

It has been reported that Apple is working with Stanford clinicians and American Well to further its smartwatch technologies and enable it to detect common heart conditions and abnormalities through the use of sensors.

If successful, the company will see a steady rise in revenue by catering towards high-risk patients, with information that is over 90% accurate. Both Stanford and American Well have declined to comment.

Related stories

At present, Apple’s Series 3 provides useful information surrounding a user’s health as a result of its interest in fitness applications. The Apple Watch app can also detect any irregularities with over 95% accuracy.

Apple’s previous partnership with health app Cardiogram has also highlighted the company’s focus in cardiology and health screening. In 2016,

However, through this new partnership, Apple will develop its technology further, especially with regards to health recovery times, and whether there is the potential for undiagnosed health conditions, such as atrial fibrillation, to be bought to light.

Share

Featured Articles

NTT & Olympus: World's First Cloud Endoscopy System

NTT and medical technology company Olympus put on a demonstration, showing the IOWN APN's low-latency capability, for the first cloud endoscopy system

Richter BioLogics' New Biopharmaceutical GMP Facility

Richter BioLogics GmbH & Co KG's a new biopharmaceutical GMP facility in Germany will boost production capabilities and local employment

GE HealthCare's Pilot Study Shows Value of Portrait Mobile

A pilot study from GE Healthcare has shown the value of Portrait Mobile Continuous Monitoring Solution, a leap in post-surgical monitoring efficiency

50% of Teens to be Affected by Myopia Globally by 2050

Telehealth & COVID-19

NVIDIA’s AI Insights for Diabetes Prevention with GluFormer

Technology & AI

Novo Nordisk's CagriSema Next Gen Weight-Loss Treatment

Medical Devices & Pharma